Prescription Drug Monitoring Programs and Opioid Prescriptions for Disability Conditions
Author
Abstract
Suggested Citation
DOI: 10.1007/s40258-020-00622-4
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Anca M. Grecu & Dhaval M. Dave & Henry Saffer, 2019.
"Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse,"
Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 38(1), pages 181-209, January.
- Dhaval M. Dave & Anca M. Grecu & Henry Saffer, 2017. "Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse," NBER Working Papers 23537, National Bureau of Economic Research, Inc.
- Andrew Goodman-Bacon, 2018. "Difference-in-Differences with Variation in Treatment Timing," NBER Working Papers 25018, National Bureau of Economic Research, Inc.
- Thomas C. Buchmueller & Colleen Carey, 2018.
"The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare,"
American Economic Journal: Economic Policy, American Economic Association, vol. 10(1), pages 77-112, February.
- Thomas C. Buchmueller & Colleen Carey, 2017. "The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare," NBER Working Papers 23148, National Bureau of Economic Research, Inc.
- Jill Horwitz & Corey S. Davis & Lynn S. McClelland & Rebecca S. Fordon & Ellen Meara, 2018. "The Problem of Data Quality in Analyses of Opioid Regulation: The Case of Prescription Drug Monitoring Programs," NBER Working Papers 24947, National Bureau of Economic Research, Inc.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali Simon, 2022.
"The Opioid Crisis, Health, Healthcare, and Crime: A Review of Quasi-Experimental Economic Studies,"
The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 15-49, September.
- Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali I. Simon, 2022. "The Opioid Crisis, Health, Healthcare, and Crime: A Review Of Quasi-Experimental Economic Studies," NBER Working Papers 29983, National Bureau of Economic Research, Inc.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Gihleb, Rania & Giuntella, Osea & Zhang, Ning, 2020.
"Prescription drug monitoring programs and neonatal outcomes,"
Regional Science and Urban Economics, Elsevier, vol. 81(C).
- Gihleb, Rania & Giuntella, Osea & Zhang, Ning, 2019. "Prescription Drug Monitoring Programs and Neonatal Outcomes," IZA Discussion Papers 12796, Institute of Labor Economics (IZA).
- Deiana Claudio & Giua Ludovica, 2021. "The Intended and Unintended Effects of Opioid Policies on Prescription Opioids and Crime," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 21(2), pages 751-792, April.
- Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2021.
"Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic,"
NBER Working Papers
29596, National Bureau of Economic Research, Inc.
- Balestra, Simone & Liebert, Helge & Maestas, Nicole & Sherry, Tisamarie B., 2022. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," IZA Discussion Papers 15221, Institute of Labor Economics (IZA).
- Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2022. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," CESifo Working Paper Series 9704, CESifo.
- Gal Wettstein, 2019. "Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision," Health Economics, John Wiley & Sons, Ltd., vol. 28(5), pages 666-677, May.
- Shishir Shakya & Collin Hodges, 2023. "Must‐access prescription drug monitoring programs and retail opioid sales," Contemporary Economic Policy, Western Economic Association International, vol. 41(1), pages 146-165, January.
- Thomas C. Buchmueller & Colleen M. Carey & Giacomo Meille, 2020. "How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program," Health Economics, John Wiley & Sons, Ltd., vol. 29(9), pages 957-974, September.
- Lindsey Rose Bullinger & Benjamin C. Ward, 2021. "What about the children? How opioid use affects child well‐being," Contemporary Economic Policy, Western Economic Association International, vol. 39(4), pages 737-759, October.
- Lucy Xiaolu Wang, 2021. "The complementarity of drug monitoring programs and health IT for reducing opioid‐related mortality and morbidity," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 2026-2046, September.
- Ericson, Keith Marzilli & Sacarny, Adam & Zhou, Annetta, 2023.
"Dangerous prescribing and healthcare fragmentation: Evidence from opioids,"
Journal of Public Economics, Elsevier, vol. 225(C).
- Keith Marzilli Ericson & Adam Sacarny & R. Annetta Zhou, 2022. "Dangerous Prescribing and Healthcare Fragmentation: Evidence from Opioids," NBER Working Papers 29992, National Bureau of Economic Research, Inc.
- Kaestner, Robert & Ziedan, Engy, 2023. "Effects of prescription opioids on employment, earnings, marriage, disability and mortality: Evidence from state opioid control policies," Labour Economics, Elsevier, vol. 82(C).
- David Cho & Alvaro Mezza & Joshua Montes, 2022. "Choices and Implications when Measuring the Local Supply of Prescription Opioids," Finance and Economics Discussion Series 2022-078, Board of Governors of the Federal Reserve System (U.S.).
- Kim, Bokyung, 2021. "Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences," Journal of Health Economics, Elsevier, vol. 75(C).
- Dhaval Dave & Monica Deza & Brady Horn, 2021.
"Prescription drug monitoring programs, opioid abuse, and crime,"
Southern Economic Journal, John Wiley & Sons, vol. 87(3), pages 808-848, January.
- Dhaval Dave & Monica Deza & Brady P. Horn, 2018. "Prescription Drug Monitoring Programs, Opioid Abuse, and Crime," NBER Working Papers 24975, National Bureau of Economic Research, Inc.
- David Cho & Daniel I. García & Joshua Montes & Alison E. Weingarden, 2021. "Labor Market Effects of the Oxycodone-Heroin Epidemic," Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.).
- Christopher J. Ruhm, 2019.
"Shackling the Identification Police?,"
Southern Economic Journal, John Wiley & Sons, vol. 85(4), pages 1016-1026, April.
- Christopher J. Ruhm, 2018. "Shackling the Identification Police?," NBER Working Papers 25320, National Bureau of Economic Research, Inc.
- Aljoscha Janssen & Xuan Zhang, 2023. "Retail Pharmacies and Drug Diversion during the Opioid Epidemic," American Economic Review, American Economic Association, vol. 113(1), pages 1-33, January.
- Molly Schnell & Janet Currie, 2018.
"Addressing the Opioid Epidemic: Is There a Role for Physician Education?,"
American Journal of Health Economics, MIT Press, vol. 4(3), pages 383-410, Summer.
- Molly Schnell & Janet Currie, 2018. "Addressing the Opioid Epidemic: Is There a Role for Physician Education?," American Journal of Health Economics, University of Chicago Press, vol. 4(3), pages 383-410, Summer.
- Molly Schnell & Janet Currie, 2017. "Addressing the Opioid Epidemic: Is There a Role for Physician Education?," NBER Working Papers 23645, National Bureau of Economic Research, Inc.
- Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali Simon, 2022.
"The Opioid Crisis, Health, Healthcare, and Crime: A Review of Quasi-Experimental Economic Studies,"
The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 15-49, September.
- Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali I. Simon, 2022. "The Opioid Crisis, Health, Healthcare, and Crime: A Review Of Quasi-Experimental Economic Studies," NBER Working Papers 29983, National Bureau of Economic Research, Inc.
- Alexander Ahammer & Analisa Packham, 2024.
"Supply-Side Drug Policy, Polydrug Use, and the Economic Effects of Withdrawal Symptoms,"
NBER Working Papers
32804, National Bureau of Economic Research, Inc.
- Ahammer, Alexander & Packham, Analisa, 2024. "Supply-Side Drug Policy, Polydrug Use, and the Economic Effects of Withdrawal Symptoms," IZA Discussion Papers 17192, Institute of Labor Economics (IZA).
- Alexander Ahammer & Analisa Packham, 2024. "Supply-side drug policy, polydrug use, and the economic effects of withdrawal symptoms," Economics working papers 2024-07, Department of Economics, Johannes Kepler University Linz, Austria.
- Alberto Ortega, 2023. "Medicaid Expansion and mental health treatment: Evidence from the Affordable Care Act," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 755-806, April.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:19:y:2021:i:3:d:10.1007_s40258-020-00622-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.